Post Content
Solar-driven biosynthesis of chemicals from phosphite-rich wastewater and carbon dioxide
Post Content
The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on...
GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
Mars may be hostile, but it might not be entirely unlivable. In lab experiments, yeast cells survived simulated Martian shock waves and toxic perchlorate salts—two major...
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Isaac Rose-Berman. Be sure to sign up for the weekly “First Opinion...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and...
More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
Post Content